Key result
Reduced lateral MAPSE and myocardial fibrosis are linked to ~12-point lower quality-of-life scores in DMD carriers.
Why the study?
A substantial minority of women carrying pathogenic Duchenne muscular dystrophy variants develop cardiac or neuromuscular involvement, yet prospective data linking objective cardiac imaging to health-related quality of life in this population were lacking.
Are objective cardiac imaging findings (such as MAPSE and late gadolinium enhancement) and caregiving status associated with health-related quality of life and self-reported symptoms in women carrying pathogenic DMD variants?
Cross-Sectional (n=30)
Are objective cardiac imaging findings (such as MAPSE and late gadolinium enhancement) and caregiving status associated with health-related quality of life and self-reported symptoms in women carrying pathogenic DMD variants?
In female carriers of pathogenic DMD variants, subclinical cardiac imaging abnormalities—specifically reduced MAPSE and myocardial fibrosis on CMR (LGE)—are common and significantly associated with worse patient-reported quality of life, supporting routine cardiac and psychosocial surveillance.
Answers are grounded in this paper and cite their sources.
Reduced lateral MAPSE and LGE were associated with worse QoL in female DMD carriers; leaves open whether imaging improves risk stratification or outcomes.
Background Women carrying pathogenic Duchenne muscular dystrophy (FC-DMD) variants are traditionally regarded as asymptomatic, yet a substantial minority develop cardiac or neuromuscular involvement, and many simultaneously act as long-term caregivers. Prospective data linking objective cardiac imaging to health-related quality of life (HRQoL) in this population are lacking. We aimed to evaluate HRQoL in a nationally recruited FC-DMD cohort, explore its associations with cardiac imaging findings and self-reported symptoms. Methods In this prospective cross-sectional study, FC-DMD were recruited through Parent Project Czech Republic, and underwent cardiological screening between September 2023 and December 2024. Of 35 eligible women approached, 30 completed study procedures (17 caregivers, 13 non-caregivers). Participants underwent clinical evaluation, echocardiography and cardiac magnetic resonance, and completed the EuroQol 5-Dimension 3-Level questionnaire (EQ-5D-3 L), the EuroQol visual analogue scale (EQ-VAS) and a study-specific questionnaire. Associations were assessed using Kendall’s τ; group comparisons used the Mann–Whitney U and Fisher’s exact tests. Results Median age was 47 years (IQR 39–50). Symptoms were frequent: 57% palpitations, 37% dyspnea, 37% myalgia and upper-limb clumsiness. 40% of participants reported moderate anxiety/depression and 33% reported moderate pain/discomfort, yet overall self-perceived health was favorable (median EQ VAS 90, IQR 75–100; median EQ-5D-3 L level-sum score 6, IQR 5–7). Late gadolinium enhancement (LGE) was present in 33% of the participants. Lower lateral mitral annular plane systolic excursion (MAPSE) was associated with a higher EQ-5D-3 L level-sum score (τ = −0.50, 95% CI − 0.70 to − 0.27). Septal MAPSE showed a similar inverse association with the EQ-5D-3 L level-sum score (τ = −0.32, 95% CI − 0.58 to − 0.02) but not with the study-specific score, and higher septal MAPSE was associated with a higher EQ-VAS score (τ = 0.32, 95% CI 0.10 to 0.55). The participants with LGE reported lower EQ VAS scores (median 78 vs. 90; p = 0.034). Conclusions FC-DMD reported generally favorable overall health despite frequent cardiopulmonary, neuromuscular and psychological symptoms. Reduced MAPSE and the presence of LGE were associated with worse patient-reported health. By integrating cardiac imaging with validated and patient-centered outcomes, FC-DMD represents an underrecognized group within the DMD community for whom continued systematic cardiac surveillance in accordance with current recommendations is essential, while psychological screening may be a valuable addition to routine follow-up. These exploratory findings require confirmation in larger, longitudinal, multicenter cohorts.
No takes yet. Share an insight, caveat, or question.
Masárová et al. (2026) conducted a cross-sectional in Female carriers of pathogenic Duchenne muscular dystrophy (FC-DMD) variants (n=30). Cardiac imaging abnormalities (reduced lateral/septal MAPSE and presence of late gadolinium enhancement [LGE]) vs. Normal cardiac imaging parameters / absence of LGE or non-caregiving status was evaluated on Health-related quality of life (EQ-5D-3L level-sum score and EQ-VAS) and its association with cardiac imaging findings (Kendall's τ = -0.50 (lateral MAPSE vs EQ-5D-3L level-sum score); median EQ-VAS 78 vs 90 for LGE presence, 95% CI -0.70 to -0.27, p=0.034). Reduced lateral MAPSE and late gadolinium enhancement were associated with worse quality of life in female DMD carriers.
Synapse has enriched 10 related papers. Consider them for comparative context: